What is the equity of Theraclion this year?
Theraclion has equity of 544,870.02 EUR this year.
Theraclion Equity 2024
Theraclion Equity
544,870.02 EUR
Ticker
ALTHE.PA
ISIN
FR0010120402
WKN
A112C8
In 2024, Theraclion's equity was 544,870.02 EUR, a -142.81% increase from the -1.27 M EUR equity in the previous year.
Theraclion Aktienanalyse
What does Theraclion do?
Theraclion SA is a French medical company specializing in the development and production of innovative therapy systems. The company was founded in 2004 and is headquartered in Malakoff, France. Theraclion's business model is based on the development and marketing of medical devices based on High Intensity Focused Ultrasound (HIFU) technology. This technology uses ultrasound pulses to treat targeted areas in the body without the need for surgical intervention. Theraclion specializes in three main areas: oncology, dermatology, and aesthetics. In the field of oncology, Theraclion has developed the Echopulse system, which is used for the treatment of breast tumors. The system applies high-intensity ultrasound pulses to kill tumor cells without damaging surrounding tissue. This non-invasive method of tumor treatment is very promising and has already shown promising results in several studies. In the field of dermatology, Theraclion has developed the Echovist system, which is used for the treatment of nevi (moles). The system also utilizes HIFU technology to destroy the nevi, resulting in a significant improvement in the aesthetic appearance of the skin. In the field of aesthetics, Theraclion has developed the Sonovein system, which is used for the treatment of varicose veins. The system also utilizes HIFU technology to close the veins and thus improve the patient's appearance and quality of life. Theraclion has experienced impressive growth in recent years and is now an important player in the medical industry. The company has filed several patents and works closely with leading doctors and research institutions to maximize the effectiveness of its products. Overall, Theraclion aims to offer innovative therapies that meet the needs of patients and help them lead fulfilling lives. The company is committed to continuously improving its products and services and strives to achieve even greater successes in the future. Theraclion ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Theraclion's Equity
Theraclion's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Theraclion's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Theraclion's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Theraclion's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Theraclion’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Theraclion Stock
What was the equity of Theraclion compared to the previous year?
The equity of Theraclion has increased/decreased by -142.81% decreased compared to the previous year.
What impact does a high equity have on investors of Theraclion?
A high equity is advantageous for investors of Theraclion as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Theraclion?
A low equity can be a risk for investors of Theraclion, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Theraclion affect the company?
An increase in equity of Theraclion can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Theraclion affect the company?
A reduction in equity of Theraclion can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Theraclion?
Some factors that can affect the equity of Theraclion include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Theraclion so important for investors?
The equity of Theraclion is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Theraclion take to change the equity?
To change equity, Theraclion can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Theraclion pay?
Over the past 12 months, Theraclion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Theraclion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Theraclion?
The current dividend yield of Theraclion is .
When does Theraclion pay dividends?
Theraclion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Theraclion?
Theraclion paid dividends every year for the past 0 years.
What is the dividend of Theraclion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Theraclion located?
Theraclion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Theraclion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Theraclion from 6/29/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/29/2024.
When did Theraclion pay the last dividend?
The last dividend was paid out on 6/29/2024.
What was the dividend of Theraclion in the year 2023?
In the year 2023, Theraclion distributed 0 EUR as dividends.
In which currency does Theraclion pay out the dividend?
The dividends of Theraclion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Theraclion
Our stock analysis for Theraclion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Theraclion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
